한글목차

세계의 간질환 진단 시장 규모는 2023년 133억 6,164만 달러에서 예측기간 동안 7.05%의 CAGR로 성장하여 2029년에는 201억 298만 달러 규모로 성장할 것으로 예측됩니다.

지역별로 보면 2022년 시장 규모는 북미 시장이 50억 1,920만 달러, 아시아태평양 시장이 30억 3,697만 달러, 유럽 시장이 36억 9,005만 달러를 나타내고 있으며, 같은 해 세계 시장의 점유율은 북미가 40.95%, 아시아태평양이 24.78%, 유럽이 30.11%를 나타내고 있습니다. 아시아태평양의 점유율은 2029년에는 28.57%에 달할 전망이며, 이 지역의 예측기간 동안 CAGR은 8.99%가 될 것으로 예측됩니다.

세계의 간질환 진단 시장을 조사했으며, 시장 및 제품 개요, 경쟁 상황, 시장 규모 추정과 예측, 각종 부문·지역/주요 국가별 상세 분석, 가격 동향, 시장 성장에 대한 각종 영향요인 분석, 주요 기업 분석 등을 정리했습니다.

목차

제1장 보고서 개요

• 조사 범위
• 시장 분석 : 유형별
  • 성장률 : 2018년 vs 2022년 vs 2029년
  • 영상 검사
  • 혈액 검사
  • 생검
• 시장 : 용도별
  • 시장 점유율 : 2018년 vs 2022년 vs 2029년
  • 병원·진료소
  • 진단 센터
  • 기타
• 가정과 제한
• 조사 목적
• 조사 기간

제2장 세계의 성장 동향

• 시장 전망
• 성장 동향 : 지역별
  • 시장 규모 : 2018년 vs 2022년 vs 2029년
  • 시장 규모 추정
  • 시장 규모 예측
• 시장 역학
  • 산업 동향
  • 시장 성장 촉진요인
  • 시장 과제
  • 시장 성장 억제요인

제3장 경쟁 상황 : 주요 기업별

• 매출·매출 점유율 : 기업별
• 시장 점유율 : 기업 유형별
• 세계의 주요 기업 : 매출 순위
• 시장 집중률
• 세계의 주요 기업 : 본사·제조 거점
• 세계의 주요 기업 : 제공 제품
• 세계의 주요 기업 : 설립일
• M&A·확장 계획

제4장 간질환 진단 내역 데이터 : 유형별

• 시장 규모 추정과 예측

제5장 간질환 진단 내역 데이터 : 용도별

• 시장 규모 추정과 예측

제6장 북미

제7장 유럽

제8장 아시아태평양

제9장 라틴아메리카

제10장 중동 및 아프리카

제11장 주요 기업 개요

• Abbott
• Roche
• Thermo Fisher Scientific
• Randox Diagnostic Centers
• Boston Scientific Corporation
• LabCorp
• Fujifilm Corporation
• Siemens Healthineers
• BD
• Cook Medical
• GE Healthcare
• Philips Healthcare
• Canon Medical Systems
• Qiagen

제12장 애널리스트에 의한 견해·결론

제13장 부록

영문목차

The global Liver Disease Diagnostics market is projected to grow from US$ 13,361.64 million in 2023 to US$ 20,102.98 million by 2029, at a Compound Annual Growth Rate (CAGR) of 7.05% during the forecast period.

North America Liver Disease Diagnostics market size is valued at US$ 5,019.20 million in 2022, while Asia Pacific and Europe Liver Disease Diagnostics are US$ 3,036.97 million and US$ 3,690.05 million, severally. The proportion of the North America is 40.95% in 2022, while APAC and Europe are 24.78% and 30.11% respectively, and it is predicted that APAC proportion will reach 28.57% in 2029, trailing a CAGR of 8.99% through the analysis period. China, Japan, South Korea, and India are noteworthy markets in APAC. As for the Europe Liver Disease Diagnostics landscape, Germany is projected to reach US$ 1,292.90 million by 2029 trailing a CAGR of 6.06% during 2023-2029.

The global key companies of Liver Disease Diagnostics include: Roche, Abbott, Thermo Fisher Scientific, Siemens Healthineers, GE Healthcare, Canon Medical Systems, LabCorp, BD, Philips Healthcare and Randox Laboratories is the leading manufacturer in global Liver Disease Diagnostics market. The top 10 listed companies accounted for 39.41% of the market share in 2022 in terms of revenue.

Report Includes:

This report presents an overview of global market for Liver Disease Diagnostics market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key producers of Liver Disease Diagnostics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Liver Disease Diagnostics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Liver Disease Diagnostics revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Liver Disease Diagnostics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Liver Disease Diagnostics revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Abbott, Roche, Thermo Fisher Scientific, Randox Diagnostic Centers, Boston Scientific Corporation, LabCorp, Fujifilm Corporation, Horiba Medical, and Siemens Healthineers, etc.

By Company

• Abbott
• Roche
• Thermo Fisher Scientific
• Randox Laboratories
• Boston Scientific
• LabCorp
• Fujifilm Corporation
• Siemens Healthineers
• BD
• Cook Medical
• GE Healthcare
• Philips Healthcare
• Canon Medical Systems
• Qiagen

Segment by Type

• Imaging Tests
• Blood Tests
• Biopsy

Segment by Application

• Hospitals and Clinics
• Diagnostic Centers
• Others

By Region

• North America
  • United States
  • Canada
  • Mexico

• Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia

• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Switzerland
  • Rest of Europe

• Latin America
  • Brazil
  • Argentina
  • Rest of Latin America

• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Rest of MEA

Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Liver Disease Diagnostics Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
  • 1.2.2 Imaging Tests
  • 1.2.3 Blood Tests
  • 1.2.4 Biopsy
• 1.3 Market by Application
  • 1.3.1 Global Liver Disease Diagnostics Market Share by Application: 2018 VS 2022 VS 2029
  • 1.3.2 Hospitals and Clinics
  • 1.3.3 Diagnostic Centers
  • 1.3.4 Others
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Liver Disease Diagnostics Market Perspective (2018-2029)
• 2.2 Global Liver Disease Diagnostics Growth Trends by Region
  • 2.2.1 Global Liver Disease Diagnostics Market Size by Region: 2018 VS 2022 VS 2029
  • 2.2.2 Liver Disease Diagnostics Historic Market Size by Region (2018-2023)
  • 2.2.3 Liver Disease Diagnostics Forecasted Market Size by Region (2024-2029)
• 2.3 Liver Disease Diagnostics Market Dynamics
  • 2.3.1 Liver Disease Diagnostics Industry Trends
  • 2.3.2 Liver Disease Diagnostics Market Drivers
  • 2.3.3 Liver Disease Diagnostics Market Challenges
  • 2.3.4 Liver Disease Diagnostics Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Revenue Liver Disease Diagnostics by Players
  • 3.1.1 Global Liver Disease Diagnostics Revenue by Players (2018-2023)
  • 3.1.2 Global Liver Disease Diagnostics Revenue Market Share by Players (2018-2023)
• 3.2 Global Liver Disease Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.3 Global Key Players of Liver Disease Diagnostics, Ranking by Revenue
• 3.4 Global Liver Disease Diagnostics Market Concentration Ratio
  • 3.4.1 Global Liver Disease Diagnostics Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Liver Disease Diagnostics Revenue in 2022
• 3.5 Global Key Players of Liver Disease Diagnostics Head office and Manufacturing Sites
• 3.6 Global Key Players of Liver Disease Diagnostics Product
• 3.7 Global Key Players of Liver Disease Diagnostics, Founded Date
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Liver Disease Diagnostics Breakdown Data by Type

• 4.1 Global Liver Disease Diagnostics Historic Market Size by Type (2018-2023)
• 4.2 Global Liver Disease Diagnostics Forecasted Market Size by Type (2024-2029)

5 Liver Disease Diagnostics Breakdown Data by Application

• 5.1 Global Liver Disease Diagnostics Historic Market Size by Application (2018-2023)
• 5.2 Global Liver Disease Diagnostics Forecasted Market Size by Application (2024-2029)

6 North America

• 6.1 North America Liver Disease Diagnostics Market Size (2018-2029)
• 6.2 North America Liver Disease Diagnostics Market Size by Type
  • 6.2.1 North America Liver Disease Diagnostics Market Size by Type (2018-2023)
  • 6.2.2 North America Liver Disease Diagnostics Market Size by Type (2024-2029)
  • 6.2.3 North America Liver Disease Diagnostics Market Share by Type (2018-2029)
• 6.3 North America Liver Disease Diagnostics Market Size by Application
  • 6.3.1 North America Liver Disease Diagnostics Market Size by Application (2018-2023)
  • 6.3.2 North America Liver Disease Diagnostics Market Size by Application (2024-2029)
  • 6.3.3 North America Liver Disease Diagnostics Market Share by Application (2018-2029)
• 6.4 North America Liver Disease Diagnostics Market Size by Country
  • 6.4.1 North America Liver Disease Diagnostics Market Size by Country (2018-2023)
  • 6.4.2 North America Liver Disease Diagnostics Market Share by Country (2024-2029)
  • 6.4.3 United States
  • 6.4.4 Canada
  • 6.4.5 Mexico

7 Europe

• 7.1 Europe Liver Disease Diagnostics Market Size (2018-2029)
• 7.2 Europe Liver Disease Diagnostics Market Size by Type
  • 7.2.1 Europe Liver Disease Diagnostics Market Size by Type (2018-2023)
  • 7.2.2 Europe Liver Disease Diagnostics Market Size by Type (2024-2029)
  • 7.2.3 Europe Liver Disease Diagnostics Market Share by Type (2018-2029)
• 7.3 Europe Liver Disease Diagnostics Market Size by Application
  • 7.3.1 Europe Liver Disease Diagnostics Market Size by Application (2018-2023)
  • 7.3.2 Europe Liver Disease Diagnostics Market Size by Application (2024-2029)
  • 7.3.3 Europe Liver Disease Diagnostics Market Share by Application (2018-2029)
• 7.4 Europe Liver Disease Diagnostics Market Size by Country
  • 7.4.1 Europe Liver Disease Diagnostics Market Size by Country (2018-2023)
  • 7.4.2 Europe Liver Disease Diagnostics Market Size by Country (2024-2029)
  • 7.4.3 Germany
  • 7.4.4 France
  • 7.4.5 U.K.
  • 7.4.6 Italy
  • 7.4.7 Switzerland

8 Asia Pacific

• 8.1 Asia Pacific Liver Disease Diagnostics Market Size (2018-2029)
• 8.2 Asia Pacific Liver Disease Diagnostics Market Size by Type
  • 8.2.1 Asia Pacific Liver Disease Diagnostics Market Size by Type (2018-2023)
  • 8.2.2 Asia Pacific Liver Disease Diagnostics Market Size by Type (2024-2029)
  • 8.2.3 Asia Pacific Liver Disease Diagnostics Market Share by Type (2018-2029)
• 8.3 Asia Pacific Liver Disease Diagnostics Market Size by Application
  • 8.3.1 Asia Pacific Liver Disease Diagnostics Market Size by Application (2018-2023)
  • 8.3.2 Asia Pacific Liver Disease Diagnostics Market Size by Application (2024-2029)
  • 8.3.3 Asia Pacific Liver Disease Diagnostics Market Share by Application (2018-2029)
• 8.4 Asia Pacific Liver Disease Diagnostics Market Size by Region
  • 8.4.1 Asia Pacific Liver Disease Diagnostics Market Size by Region (2018-2023)
  • 8.4.2 Asia Pacific Liver Disease Diagnostics Market Size by Region (2024-2029)
  • 8.4.3 China
  • 8.4.4 Japan
  • 8.4.5 South Korea
  • 8.4.6 Southeast Asia
  • 8.4.7 India
  • 8.4.8 Australia

9 Latin America

• 9.1 Latin America Liver Disease Diagnostics Market Size (2018-2029)
• 9.2 Latin America Liver Disease Diagnostics Market Size by Type
  • 9.2.1 Latin America Liver Disease Diagnostics Market Size by Type (2018-2023)
  • 9.2.2 Latin America Liver Disease Diagnostics Market Size by Type (2024-2029)
  • 9.2.3 Latin America Liver Disease Diagnostics Market Share by Type (2018-2029)
• 9.3 Latin America Liver Disease Diagnostics Market Size by Application
  • 9.3.1 Latin America Liver Disease Diagnostics Market Size by Application (2018-2023)
  • 9.3.2 Latin America Liver Disease Diagnostics Market Size by Application (2024-2029)
  • 9.3.3 Latin America Liver Disease Diagnostics Market Share by Application (2018-2029)
• 9.4 Latin America Liver Disease Diagnostics Market Size by Country
  • 9.4.1 Latin America Liver Disease Diagnostics Market Size by Country (2018-2023)
  • 9.4.2 Latin America Liver Disease Diagnostics Market Size by Country (2024-2029)
  • 9.4.3 Brazil
  • 9.4.4 Argentina

10 Middle East & Africa

• 10.1 Middle East & Africa Liver Disease Diagnostics Market Size (2018-2029)
• 10.2 Middle East & Africa Liver Disease Diagnostics Market Size by Type
  • 10.2.1 Middle East & Africa Liver Disease Diagnostics Market Size by Type (2018-2023)
  • 10.2.2 Middle East & Africa Liver Disease Diagnostics Market Size by Type (2024-2029)
  • 10.2.3 Middle East & Africa Liver Disease Diagnostics Market Share by Type (2018-2029)
• 10.3 Middle East & Africa Liver Disease Diagnostics Market Size by Application
  • 10.3.1 Middle East & Africa Liver Disease Diagnostics Market Size by Application (2018-2023)
  • 10.3.2 Middle East & Africa Liver Disease Diagnostics Market Size by Application (2024-2029)
  • 10.3.3 Middle East & Africa Liver Disease Diagnostics Market Share by Application (2018-2029)
• 10.4 Middle East & Africa Liver Disease Diagnostics Market Size by Country
  • 10.4.1 Middle East & Africa Liver Disease Diagnostics Market Size by Country (2018-2023)
  • 10.4.2 Middle East & Africa Liver Disease Diagnostics Market Size by Country (2024-2029)
  • 10.4.3 Saudi Arabia
  • 10.4.4 UAE
  • 10.4.5 Israel

11 Key Players Profiles

• 11.1 Abbott
  • 11.1.1 Abbott Company Details
  • 11.1.2 Abbott Business Overview
  • 11.1.3 Abbott Liver Disease Diagnostics Introduction
  • 11.1.4 Abbott Revenue in Liver Disease Diagnostics Business (2018-2023)
  • 11.1.5 Abbott Recent Development
• 11.2 Roche
  • 11.2.1 Roche Company Details
  • 11.2.2 Roche Business Overview
  • 11.2.3 Roche Liver Disease Diagnostics Introduction
  • 11.2.4 Roche Revenue in Liver Disease Diagnostics Business (2018-2023)
  • 11.2.5 Roche Recent Development
• 11.3 Thermo Fisher Scientific
  • 11.3.1 Thermo Fisher Scientific Company Details
  • 11.3.2 Thermo Fisher Scientific Business Overview
  • 11.3.3 Thermo Fisher Scientific Liver Disease Diagnostics Introduction
  • 11.3.4 Thermo Fisher Scientific Revenue in Liver Disease Diagnostics Business (2018-2023)
• 11.4 Randox Diagnostic Centers
  • 11.4.1 Randox Diagnostic Centers Company Details
  • 11.4.2 Randox Diagnostic Centers Business Overview
  • 11.4.3 Randox Diagnostic Centers Liver Disease Diagnostics Introduction
  • 11.4.4 Randox Diagnostic Centers Revenue in Liver Disease Diagnostics Business (2018-2023)
  • 11.4.5 Randox Diagnostic Centers Recent Development
• 11.5 Boston Scientific Corporation
  • 11.5.1 Boston Scientific Corporation Company Details
  • 11.5.2 Boston Scientific Corporation Business Overview
  • 11.5.3 Boston Scientific Corporation Liver Disease Diagnostics Introduction
  • 11.5.4 Boston Scientific Corporation Revenue in Liver Disease Diagnostics Business (2018-2023)
• 11.6 LabCorp
  • 11.6.1 LabCorp Company Details
  • 11.6.2 LabCorp Business Overview
  • 11.6.3 LabCorp Liver Disease Diagnostics Introduction
  • 11.6.4 LabCorp Revenue in Liver Disease Diagnostics Business (2018-2023)
  • 11.6.5 LabCorp Recent Development
• 11.7 Fujifilm Corporation
  • 11.7.1 Fujifilm Corporation Company Details
  • 11.7.2 Fujifilm Corporation Business Overview
  • 11.7.3 Fujifilm Corporation Liver Disease Diagnostics Introduction
  • 11.7.4 Fujifilm Corporation Revenue in Liver Disease Diagnostics Business (2018-2023)
• 11.8 Siemens Healthineers
  • 11.8.1 Siemens Healthineers Company Details
  • 11.8.2 Siemens Healthineers Business Overview
  • 11.8.3 Siemens Healthineers Liver Disease Diagnostics Introduction
  • 11.8.4 Siemens Healthineers Revenue in Liver Disease Diagnostics Business (2018-2023)
• 11.9 BD
  • 11.9.1 BD Company Details
  • 11.9.2 BD Business Overview
  • 11.9.3 BD Liver Disease Diagnostics Introduction
  • 11.9.4 BD Revenue in Liver Disease Diagnostics Business (2018-2023)
• 11.10 Cook Medical
  • 11.10.1 Cook Medical Company Details
  • 11.10.2 Cook Medical Business Overview
  • 11.10.3 Cook Medical Liver Disease Diagnostics Introduction
  • 11.10.4 Cook Medical Revenue in Liver Disease Diagnostics Business (2018-2023)
• 11.11 GE Healthcare
  • 11.11.1 GE Healthcare Company Details
  • 11.11.2 GE Healthcare Business Overview
  • 11.11.3 GE Healthcare Liver Disease Diagnostics Introduction
  • 11.11.4 GE Healthcare Revenue in Liver Disease Diagnostics Business (2018-2023)
• 11.12 Philips Healthcare
  • 11.12.1 Philips Healthcare Company Details
  • 11.12.2 Philips Healthcare Business Overview
  • 11.12.3 Philips Healthcare Liver Disease Diagnostics Introduction
  • 11.12.4 Philips Healthcare Revenue in Liver Disease Diagnostics Business (2018-2023)
  • 11.12.5 Philips Healthcare Recent Development
• 11.13 Canon Medical Systems
  • 11.13.1 Canon Medical Systems Company Details
  • 11.13.2 Canon Medical Systems Business Overview
  • 11.13.3 Canon Medical Systems Liver Disease Diagnostics Introduction
  • 11.13.4 Canon Medical Systems Revenue in Liver Disease Diagnostics Business (2018-2023)
  • 11.13.5 Canon Medical Systems Recent Development
• 11.14 Qiagen
  • 11.14.1 Qiagen Company Details
  • 11.14.2 Qiagen Business Overview
  • 11.14.3 Qiagen Liver Disease Diagnostics Introduction
  • 11.14.4 Qiagen Revenue in Liver Disease Diagnostics Business (2018-2023)

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Author Details
• 13.3 Disclaimer